153 related articles for article (PubMed ID: 25962188)
1. Special report: cost-effectiveness studies of new hepatitis C treatments.
Mark DH;
Technol Eval Cent Assess Program Exec Summ; 2015 Jan; 29(10):1-3. PubMed ID: 25962188
[No Abstract] [Full Text] [Related]
2. The price of good health.
Nat Med; 2014 Apr; 20(4):319. PubMed ID: 24710362
[TBL] [Abstract][Full Text] [Related]
3. [Therapy spectrum in hepatitis C extended. Newer NS3/4A protease inhibitor in chronic hepatitis C-GT1/4 infection].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():53. PubMed ID: 25026860
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness of novel regimens for the treatment of hepatitis C virus.
Najafzadeh M; Andersson K; Shrank WH; Krumme AA; Matlin OS; Brennan T; Avorn J; Choudhry NK
Ann Intern Med; 2015 Mar; 162(6):407-19. PubMed ID: 25775313
[TBL] [Abstract][Full Text] [Related]
5. WHO issues guidelines on HCV amid drug cost controversy.
Slomski A
JAMA; 2014 Jun; 311(22):2262-3. PubMed ID: 24915242
[No Abstract] [Full Text] [Related]
6. [A new era in therapy of chronic hepatitis C].
Füessl HS
MMW Fortschr Med; 2015 Feb; 157(2):38. PubMed ID: 25743515
[No Abstract] [Full Text] [Related]
7. [New combination therapy increases chances of recovery].
Jäger-Becker D
MMW Fortschr Med; 2015 Feb; 157(3):70. PubMed ID: 25743682
[No Abstract] [Full Text] [Related]
8. The comparative clinical effectiveness and value of simeprevir and sofosbuvir for chronic hepatitis C virus infection.
Ollendorf DA; Tice JA; Pearson SD
JAMA Intern Med; 2014 Jul; 174(7):1170-1. PubMed ID: 24798321
[No Abstract] [Full Text] [Related]
9. Medicine. Hepatitis C can be cured globally, but at what cost?
Hill A; Cooke G
Science; 2014 Jul; 345(6193):141-2. PubMed ID: 25013048
[No Abstract] [Full Text] [Related]
10. [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis].
MMW Fortschr Med; 2014 Dec; 156(21-22):97. PubMed ID: 25608420
[No Abstract] [Full Text] [Related]
11. The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C.
Younossi Z; Henry L
Dig Liver Dis; 2014 Dec; 46 Suppl 5():S186-96. PubMed ID: 25458773
[TBL] [Abstract][Full Text] [Related]
12. Chronic viral hepatitis. Treatment progress, hopes for cures.
Mayo Clin Health Lett; 2014 Mar; 32(3):4-5. PubMed ID: 24696905
[No Abstract] [Full Text] [Related]
13. The high price of the new hepatitis C virus drugs.
Steinbrook R; Redberg RF
JAMA Intern Med; 2014 Jul; 174(7):1172. PubMed ID: 24798183
[No Abstract] [Full Text] [Related]
14. [Naturopathy consultation. Soon all patients will be curable. Decisive breakthrough in therapy of hepatitis C ].
Einecke D
MMW Fortschr Med; 2014 Feb; 156(3):26-7. PubMed ID: 24938054
[No Abstract] [Full Text] [Related]
15. Treatment of chronic hepatitis C virus infection in the near future.
Cheinquer H
Ann Hepatol; 2013; 12(6):854-9. PubMed ID: 24114813
[No Abstract] [Full Text] [Related]
16. A window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act.
Haley SJ; Kreek MJ
Am J Public Health; 2015 Mar; 105(3):457-63. PubMed ID: 25602859
[TBL] [Abstract][Full Text] [Related]
17. Simeprevir (Olysio) for chronic hepatitis C.
Med Lett Drugs Ther; 2014 Jan; 56(1433):1-3. PubMed ID: 24419295
[No Abstract] [Full Text] [Related]
18. [Is more expensive always better?].
Drenth JP
Ned Tijdschr Geneeskd; 2014; 159():A8556. PubMed ID: 25534272
[TBL] [Abstract][Full Text] [Related]
19. [On the brink of a new era in the treatment of chronic hepatitis C virus infection in Denmark].
Eiset AH; Holm MP; Leutscher PD
Ugeskr Laeger; 2014 Jul; 176(30):. PubMed ID: 25292241
[TBL] [Abstract][Full Text] [Related]
20. Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy.
Pho MT; Linas BP
Hepatology; 2014 Jul; 60(1):12-4. PubMed ID: 24825115
[No Abstract] [Full Text] [Related]
[Next] [New Search]